Diabetes in older adults: A consensus report

Journal of the American Geriatrics Society

Volumn 60, Issue 12, 2012, Pages 2342-2356

  Sue Kirkman, M ^a   Briscoe, Vanessa Jones ^b   Clark, Nathaniel ^c   Florez, Hermes ^d   Haas, Linda B ^e   Halter, Jeffrey B ^f   Huang, Elbert S ^g   Korytkowski, Mary T ^h   Munshi, Medha N ⁱ   Odegard, Peggy Soule ^j   Pratley, Richard E ^k   Swift, Carrie S ^l  

^a AMERICAN DIABETES ASSOCIATION   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c Diabetes Center of Cape Cod   (United States)

^d UNIVERSITY OF MIAMI   (United States)

^e VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^f UNIVERSITY OF MICHIGAN   (United States)

^g UNIVERSITY OF CHICAGO   (United States)

^h UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j UNIVERSITY OF WASHINGTON   (United States)

^k FLORIDA HOSPITAL   (United States)

^l Kadlec Medical Center   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLSALICYLIC ACID; ALPHA GLUCOSIDASE INHIBITOR; BROMOCRIPTINE; COLESEVELAM; DIPEPTIDYL PEPTIDASE IV INHIBITOR; FENOFIBRATE; GLIBENCLAMIDE; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; GLUCOSE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; PRAMLINTIDE; PRAVASTATIN; SULFONYLUREA; ANTIDIABETIC AGENT;

AFRICAN AMERICAN; AGE; AGED; ANXIETY DISORDER; APPETITE DISORDER; ARTICLE; BLADDER CANCER; BLOOD PRESSURE REGULATION; BODY WEIGHT; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; COGNITIVE DEFECT; COMORBIDITY; CORONARY ARTERY DISEASE; DEPRESSION; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE PREDISPOSITION; DRUG COST; DRUG DOSE REDUCTION; DRUG HYPERSENSITIVITY; DYSLIPIDEMIA; EDEMA; ETHNICITY; FALLING; FITNESS; FRACTURE; FUNCTIONAL DISEASE; GASTROINTESTINAL HEMORRHAGE; GERIATRIC NUTRITION; GERIATRIC PATIENT; GLUCOSE BRAIN LEVEL; GLYCEMIC CONTROL; HEALTH CENTER; HEARING IMPAIRMENT; HEART FAILURE; HEMOGLOBIN BLOOD LEVEL; HISPANIC; HUMAN; HYPOGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN TREATMENT; LACTIC ACIDOSIS; LIFE EXPECTANCY; LONG TERM CARE; NAUSEA; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; PATIENT DECISION MAKING; PATIENT EDUCATION; PHYSICAL ACTIVITY; POLYPHARMACY; PRACTICE GUIDELINE; RACE DIFFERENCE; RISK ASSESSMENT; SCREENING TEST; SELF CARE; SIDE EFFECT; SLEEP DISORDER; SOCIAL ISOLATION; SYSTOLIC BLOOD PRESSURE; URINE INCONTINENCE; VISUAL IMPAIRMENT; CONFERENCE PAPER; CONSENSUS DEVELOPMENT;

AGED; DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; HYPOGLYCEMIC AGENTS;

EID: 84870989233     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.12035     Document Type: Article

References (131)

1. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011, p 2011.
2. Brown AF, Mangione CM, Saliba D, et al. California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc 2003; 51 (Suppl. Guidelines): S265-S280.
3. Szoke E, Shrayyef MZ, Messing S, et al. Effect of aging on glucose homeostasis: Accelerated deterioration of bet-cell function in individuals with impaired glucose tolerance. Diabetes Care 2008; 31: 539-543.
4. Chang AM, Halter JB,. Aging and insulin secretion. Am J Physiol Endocrinol Metab 2003; 284: E7-E12.
5. Boyle JP, Thompson TJ, Gregg EW, et al. Projection of the year 2050 burden of diabetes in the US adult population: Dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr 2010; 8: 29.
6. Narayan KM, Boyle JP, Geiss LS, et al. Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050. Diabetes Care 2006; 29: 2114-2116.
7. Selvin E, Coresh J, Brancati FL,. The burden and treatment of diabetes in elderly individuals in the U.S. Diabetes Care 2006; 29: 2415-2419.
8. Li Y, Burrows NR, Gregg EW, et al. Declining rates of hospitalization for nontraumatic lower-extremity amputation in the diabetic population aged 40 years or older: U.S., 1988-2008. Diabetes Care 2012; 35: 273-277.
9. Centers for Disease Control and Prevention. Diabetes public health resource, Available at http://www.cdc.gov/diabetes Accessed September 27, 2012.
10. Schütt M, Fach EM, Seufert J, et al. Multiple complications and frequent severe hypoglycaemia in 'elderly' and 'old' patients with type 1 diabetes. Diabet Med 2012; 29: e176-e179.
11. Amati F, Dubé JJ, Coen PM, et al. Physical inactivity and obesity underlie the insulin resistance of aging. Diabetes Care 2009; 32: 1547-1549.
12. Knowler WC, Barrett-Connor E, Fowler SE, et al. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
13. Reers C, Erbel S, Esposito I, et al. Impaired islet turnover in human donor pancreata with aging. Eur J Endocrinol 2009; 160: 185-191.
14. Maedler K, Schumann DM, Schulthess F, et al. Aging correlates with decreased bet-cell proliferative capacity and enhanced sensitivity to apoptosis: A potential role for Fas and pancreatic duodenal homeobox-1. Diabetes 2006; 55: 2455-2462.
15. Rankin MM, Kushner JA,. Adaptive cell proliferation is severely restricted with advanced age. Diabetes 2009; 58: 1365-1372.
16. American Diabetes Association. Standards of medical care in diabetes-2012 (Position Statement). Diabetes Care 2012; 35 (Suppl. 1): S11-S63.
17. Crandall J, Schade D, Ma Y, et al. Diabetes Prevention Program Research Group. The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes. J Gerontol A Biol Sci Med Sci 2006; 61A: 1075-1081.
18. Knowler WC, Fowler SE, Hamman RF, et al. Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009; 374: 1677-1686.
19. Brown JS, Wing R, Barrett-Connor E, et al. Diabetes Prevention Program Research Group. Lifestyle intervention is associated with lower prevalence of urinary incontinence: The Diabetes Prevention Program. Diabetes Care 2006; 29: 385-390.
20. Florez H, Pan Q, Ackermann RT, et al. for the Diabetes Prevention Program Research Group. Impact of lifestyle intervention and metformin on health-related quality of life: the Diabetes Prevention Program Randomized Trial. J Gen Intern Med. June 13, 2012 [Epub ahead of print]
21. Crandall JP, Knowler WC, Kahn SE, et al. Diabetes Prevention Program Research Group. The prevention of type 2 diabetes. Nat Clin Pract Endocrinol Metab 2008; 4: 382-393.
22. Ackermann RT, Finch EA, Brizendine E, et al. Translating the Diabetes Prevention Program into the community: The DEPLOY Pilot Study. Am J Prev Med 2008; 35: 357-363.
23. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
24. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352: 854-865.
25. Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359: 1577-1589.
26. Gerstein HC, Miller ME, Byington RP, et al. Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545-2559.
27. Miller ME, Bonds DE, Gerstein HC, et al. ACCORD Investigators. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: Post hoc epidemiological analysis of the ACCORD study. BMJ 2010; 340: b5444.
28. Patel A, MacMahon S, Chalmers J, et al. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-2572.
29. Duckworth W, Abraira C, Moritz T, et al. VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360: 129-139.
30. Duckworth WC, Abraira C, Moritz TE, et al. Investigators of the VADT. The duration of diabetes affects the response to intensive glucose control in type 2 subjects: The VA Diabetes Trial. J Diabetes Complications 2011; 25: 355-361.
31. Skyler JS, Bergenstal R, Bonow RO, et al. American Diabetes Association; American College of Cardiology Foundation; American Heart Association. Intensive glycemic control and the prevention of cardiovascular events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care 2009; 32: 187-192.
32. Araki A, Iimuro S, Sakurai T, et al. Japanese Elderly Diabetes Intervention Trial Study Group. Long-term multiple risk factor interventions in Japanese elderly diabetic patients: The Japanese Elderly Diabetes Intervention Trial-study design, baseline characteristics and effects of intervention. Geriatr Gerontol Int 2012; 12 (Suppl. 1): 7-17.
33. Currie CJ, Peters JR, Tynan A, et al. Survival as a function of HbA(1c) in people with type 2 diabetes: A retrospective cohort study. Lancet 2010; 375: 481-489.
34. Huang ES, Liu JY, Moffet HH, et al. Glycemic control, complications, and death in older diabetic patients: The Diabetes and Aging Study. Diabetes Care 2011; 34: 1329-1336.
35. Piette JD, Kerr EA,. The impact of comorbid chronic conditions on diabetes care. Diabetes Care 2006; 29: 725-731.
36. Laiteerapong N, Huang ES, Chin MH,. Prioritization of care in adults with diabetes and comorbidity. Ann N Y Acad Sci 2011; 1243: 69-87.
37. Greenfield S, Billimek J, Pellegrini F, et al. Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: A cohort study. Ann Intern Med 2009; 151: 854-860.
38. Collins R, Armitage J,. High-risk elderly patients PROSPER from cholesterol-lowering therapy. Lancet 2002; 360: 1618-1619.
39. Shepherd J, Blauw GJ, Murphy MB, et al. PROSPER (PROspective Study of Pravastatin in the Elderly at Risk) study group. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomised controlled trial. Lancet 2002; 360: 1623-1630.
40. Baigent C, Keech A, Kearney PM, et al. Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: Prospective met-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267-1278.
41. Cigolle CT, Blaum CS, Halter JB,. Diabetes and cardiovascular disease prevention in older adults. Clin Geriatr Med 2009; 25: 607-641, vii-viii.
42. Ginsberg HN, Elam MB, Lovato LC, et al. ACCORD Study Group. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med 2010; 362: 1563-1574.
43. Keech A, Simes RJ, Barter P, et al. FIELD study investigators. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): Randomised controlled trial. Lancet 2005; 366: 1849-1861.
44. Hansson L, Zanchetti A, Carruthers SG, et al. HOT Study Group. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 1755-1762.
45. Cushman WC, Evans GW, Byington RP, et al. ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010; 362: 1575-1585.
46. Cooper-DeHoff RM, Gong Y, Handberg EM, et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA 2010; 304: 61-68.
47. Anderson RJ, Bahn GD, Moritz TE, et al. VADT Study Group. Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial. Diabetes Care 2011; 34: 34-38.
48. Baigent C, Blackwell L, Collins R, et al. Antithrombotic Trialists' (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: Collaborative met-analysis of individual participant data from randomised trials. Lancet 2009; 373: 1849-1860.
49. Ogawa H, Nakayama M, Morimoto T, et al. Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial Investigators. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: A randomized controlled trial. JAMA 2008; 300: 2134-2141.
50. Hernández-Díaz S,. García Rodríguez LA. Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications. BMC Med 2006; 4: 22.
51. De Berardis G, Lucisano G, D'Ettorre A, et al. Association of aspirin use with major bleeding in patients with and without diabetes. JAMA 2012; 307: 2286-2294.
52. Abraham NS, Hlatky MA, Antman EM, et al. ACCF/ACG/AHA. ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: A focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Am J Gastroenterol 2010; 2010 (105): 2533-2549.
53. Li R, Zhang P, Barker LE, et al. Cost-effectiveness of interventions to prevent and control diabetes mellitus: A systematic review. Diabetes Care 2010; 33: 1872-1894.
54. Agardh E, Tababat-Khani P,. Adopting 3-year screening intervals for sight-threatening retinal vascular lesions in type 2 diabetic subjects without retinopathy. Diabetes Care 2011; 34: 1318-1319.
55. United States Department of Veterans Affairs. VA/DOD clinical practice guidelines: Management of diabetes mellitus in primary care, 2010. Available at http://www.healthquality.va.gov/Diabetes-Mellitus.asp Accessed September 27, 2012.
56. Sinclair AJ, Paolisso G, Castro M, et al. Rodriguez Mañas L; European Diabetes Working Party for Older People. European Diabetes Working Party for Older People 2011 clinical guidelines for type 2 diabetes mellitus: Executive summary. Diabetes Metab 2011; 37 (Suppl. 3): S27-S38.
57. Laiteerapong N, Karter AJ, Liu JY, et al. Correlates of quality of life in older adults with diabetes: The Diabetes & Aging Study. Diabetes Care 2011; 34: 1749-1753.
58. Lu FP, Lin KP, Kuo HK,. Diabetes and the risk of multi-system aging phenotypes: A systematic review and met-analysis. PLoS ONE 2009; 4: e4144.
59. Punthakee Z, Miller ME, Launer LJ, et al. ACCORD Group of Investigators; ACCORD-MIND Investigators. Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: Post hoc epidemiologic analysis of the ACCORD trial. Diabetes Care 2012; 35: 787-793.
60. Launer LJ, Miller ME, Williamson JD, et al. ACCORD MIND investigators. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): A randomised open-label substudy. Lancet Neurol 2011; 10: 969-977.
61. Cukierman T, Gerstein HC, Williamson JD,. Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies. Diabetologia 2005; 48: 2460-2469.
62. Whitmer RA, Karter AJ, Yaffe K, et al. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 2009; 301: 1565-1572.
63. Gregg EW, Mangione CM, Cauley JA, et al. Study of Osteoporotic Fractures Research Group. Diabetes and incidence of functional disability in older women. Diabetes Care 2002; 25: 61-67.
64. Gregg EW, Sorlie P, Paulose-Ram R, et al. Prevalence of lower-extremity disease in the U.S. adult population ≥ 40 years of age with and without diabetes: 1999-2000 National Health and Nutrition Examination Survey. Diabetes Care 2004; 27: 1591-1597.
65. Richardson JK, Thies SB, DeMott TK, et al. Gait analysis in a challenging environment differentiates between fallers and nonfallers among older patients with peripheral neuropathy. Arch Phys Med Rehabil 2005; 86: 1539-1544.
66. Richardson JK, Thies S, Ashton-Miller JA,. An exploration of step time variability on smooth and irregular surfaces in older persons with neuropathy. Clin Biomech (Bristol, Avon) 2008; 23: 349-356.
67. Menz HB, Lord SR,. St George R, Fitzpatrick RC. Walking stability and sensorimotor function in older people with diabetic peripheral neuropathy. Arch Phys Med Rehabil 2004; 85: 245-252.
68. Volpato S, Blaum C, Resnick H, et al. Comorbidities and impairments explaining the association between diabetes and lower extremity disability: The Women's Health and Aging Study. Diabetes Care 2002; 25: 678-683.
69. Volpato S, Leveille SG, Blaum C, et al. Risk factors for falls in older disabled women with diabetes: The Women's Health and Aging Study. J Gerontol A Biol Sci Med Sci 2005; 60A: 1539-1545.
70. Schwartz AV, Hillier TA, Sellmeyer DE, et al. Older women with diabetes have a higher risk of falls: A prospective study. Diabetes Care 2002; 25: 1749-1754.
71. The American Geriatrics Society. AGS/BGS clinical practice guideline: Prevention of falls in older persons, 2010. Available at http://www. americangeriatrics.org/health-care-professionals/clinical-practice/ clinical-guidelines-recommendations//2010/ Accessed September 27, 2012.
72. Dailey G,. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes. Clin Ther 2011; 33: 665-678.
73. Fulton MM, Allen ER,. Polypharmacy in the elderly: A literature review. J Am Acad Nurse Pract 2005; 17: 123-132.
74. Huang ES, Karter AJ, Danielson KK, et al. The association between the number of prescription medications and incident falls in a multi-ethnic population of adult type-2 diabetes patients: The Diabetes and Aging Study. J Gen Intern Med 2010; 25: 141-146.
75. Nouwen A, Winkley K, Twisk J, et al. European Depression in Diabetes (EDID) Research Consortium. Type 2 diabetes mellitus as a risk factor for the onset of depression: A systematic review and met-analysis. Diabetologia 2010; 53: 2480-2486.
76. Lin EH, Katon W, Von Korff M, et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care 2004; 27: 2154-2160.
77. Katon W, Lyles CR, Parker MM, et al. Association of depression with increased risk of dementia in patients with type 2 diabetes: The Diabetes and Aging Study. Arch Gen Psychiatry 2012; 69: 410-417.
78. Katon WJ, Rutter C, Simon G, et al. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 2005; 28: 2668-2672.
79. Montorio I, Izal M,. The Geriatric Depression Scale: A review of its development and utility. Int Psychogeriatr 1996; 8: 103-112.
80. Centers for Disease Control and Prevention. Vision Health Initiative. Available at http://www.cdc.gov/visionhealth/data/index.htm Accessed September 27, 2012.
81. Bainbridge KE, Hoffman HJ, Cowie CC,. Diabetes and hearing impairment in the United States: Audiometric evidence from the National Health and Nutrition Examination Survey, 1999 to 2004. Ann Intern Med 2008; 149: 1-10.
82. Bainbridge KE, Hoffman HJ, Cowie CC,. Risk factors for hearing impairment among U.S. adults with diabetes: National Health and Nutrition Examination Survey 1999-2004. Diabetes Care 2011; 34: 1540-1545.
83. Miller CKEL, Edwards L, Kissling G, et al. Nutrition education improves metabolic outcomes among older adults with diabetes mellitus: Results from a randomized controlled trial. Prev Med 2002; 34: 252-259.
84. Villareal DT, Banks M, Siener C, et al. Physical frailty and body composition in obese elderly men and women. Obes Res 2004; 12: 913-920.
85. Villareal DT, Banks M, Sinacore DR, et al. Effect of weight loss and exercise on frailty in obese older adults. Arch Intern Med 2006; 166: 860-866.
86. Miller SL, Wolfe RR,. The danger of weight loss in the elderly. J Nutr Health Aging 2008; 12: 487-491.
87. Shapses SA, Riedt CS,. Bone, body weight, and weight reduction: What are the concerns? J Nutr 2006; 136: 1453-1456.
88. Suhl E, Bonsignore P,. Diabetes self-management education for older adults: General principles and practical application. Diabetes Spectrum 2006; 19: 234-240.
89. Park SW, Goodpaster BH, Strotmeyer ES, et al. Decreased muscle strength and quality in older adults with type 2 diabetes: The Health, Aging, and Body Composition Study. Diabetes 2006; 55: 1813-1818.
90. Villareal DT, Chode S, Parimi N, et al. Weight loss, exercise, or both and physical function in obese older adults. N Engl J Med 2011; 364: 1218-1229.
91. Jakicic JM, Jaramillo SA, Balasubramanyam A, et al. Look AHEAD Study Group. Effect of a lifestyle intervention on change in cardiorespiratory fitness in adults with type 2 diabetes: Results from the Look AHEAD Study. Int J Obes (Lond) 2009; 33: 305-316.
92. Buman MP, Hekler EB, Haskell WL, et al. Objective light-intensity physical activity associations with rated health in older adults. Am J Epidemiol 2010; 172: 1155-1165.
93. Lipska KJ, Bailey CJ, Inzucchi SE,. Use of metformin in the setting of mild-to-moderate renal insufficiency. Diabetes Care 2011; 34: 1431-1437.
94. Shorr RI, Ray WA, Daugherty JR, et al. Individual sulfonylureas and serious hypoglycemia in older people. J Am Geriatr Soc 1996; 44: 751-755.
95. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes: A patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012; 35: 1364-1379.
96. National Institute for Health and Clinical Excellence. The management of type 2 diabetes: 2010 NICE guidelines. Available at http://www.nice.org.uk/ nicemedia/live/12165/44320/44320.pdf Accessed September 27, 2012.
97. American Geriatrics Society. Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012; 2012 (60): 616-631.
98. Herman WH, Ilag LL, Johnson SL, et al. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care 2005; 28: 1568-1573.
99. Lee P, Chang A, Blaum C, et al. Comparison of safety and efficacy of insulin glargine and neutral protamine hagedorn insulin in older adults with type 2 diabetes mellitus: Results from a pooled analysis. J Am Geriatr Soc 2012; 60: 51-59.
100. Matyka K, Evans M, Lomas J, et al. Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care 1997; 20: 135-141.
101. Bremer JP, Jauch-Chara K, Hallschmid M, et al. Hypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes. Diabetes Care 2009; 32: 1513-1517.
102. Shorr RI, Ray WA, Daugherty JR, et al. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med 1997; 157: 1681-1686.
103. Zammitt NN, Frier BM,. Hypoglycemia in type 2 diabetes: Pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care 2005; 28: 2948-2961.
104. Arias E,. United States life tables, 2007. Natl Vital Stat Rep 2011; 59: 1-60.
105. Yourman LC, Lee SJ, Schonberg MA, et al. Prognostic indices for older adults: A systematic review. JAMA 2012; 307: 182-192.
106. Lee SJ, Lindquist K, Segal MR, et al. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 2006; 295: 801-808.
107. Schonberg MA, Davis RB, McCarthy EP, et al. Index to predict 5-year mortality of community-dwelling adults aged 65 and older using data from the National Health Interview Survey. J Gen Intern Med 2009; 24: 1115-1122.
108. Wells BJ, Jain A, Arrigain S, et al. Predicting 6-year mortality risk in patients with type 2 diabetes. Diabetes Care 2008; 31: 2301-2306.
109. McEwen LN, Kim C, Karter AJ, et al. Risk factors for mortality among patients with diabetes: The Translating Research Into Action for Diabetes (TRIAD) Study. Diabetes Care 2007; 30: 1736-1741.
110. Huang ES, Zhang Q, Gandra N, et al. The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: A decision analysis. Ann Intern Med 2008; 149: 11-19.
111. Kassirer JP,. Incorporating patients' preferences into medical decisions. N Engl J Med 1994; 330: 1895-1896.
112. Barry MJ, Edgman-Levitan S,. Shared decision making-pinnacle of patient-centered care. N Engl J Med 2012; 366: 780-781.
113. Montori VM, Gafni A, Charles C,. A shared treatment decision-making approach between patients with chronic conditions and their clinicians: The case of diabetes. Health Expect 2006; 9: 25-36.
114. Huang ES, Gorawar-Bhat R, Chin MH,. Self-reported goals of older patients with type 2 diabetes mellitus. J Am Geriatr Soc 2005; 53: 306-311.
115. Huang ES, Brown SE, Ewigman BG, et al. Patient perceptions of quality of life with diabetes-related complications and treatments. Diabetes Care 2007; 30: 2478-2483.
116. Brown SE, Meltzer DO, Chin MH, et al. Perceptions of quality-of-life effects of treatments for diabetes mellitus in vulnerable and nonvulnerable older patients. J Am Geriatr Soc 2008; 56: 1183-1190.
117. Tsevat J, Dawson NV, Wu AW, et al. Health values of hospitalized patients 80 years or older. HELP Investigators. Hospitalized Elderly Longitudinal Project. JAMA 1998; 279: 371-375.
118. Traylor AH, Subramanian U, Uratsu CS, et al. Patient race/ethnicity and patient-physician race/ethnicity concordance in the management of cardiovascular disease risk factors for patients with diabetes. Diabetes Care 2010; 33: 520-525.
119. Committee on Understanding Eliminating Racial Ethnic Disparities in Health Care. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care (with CD). In: Smedley BD, Stith AY, Nelson AR, eds. Washington, DC: National Academies Press, 2003.
120. Resnick HE, Heineman J, Stone R, et al. Diabetes in U.S. nursing homes, 2004. Diabetes Care 2008; 31: 287-288.
121. Maurer MSBJ, Burcham J, Cheng H,. Diabetes mellitus is associated with an increased risk of falls in elderly residents of a long-term care facility. J Gerontol A Biol Sci Med Sci 2005; 60A: 1157-1162.
122. Travis SS, Buchanan RJ, Wang S, et al. Analyses of nursing home residents with diabetes at admission. J Am Med Dir Assoc 2004; 5: 320-327.
123. Dorner B, Friedrich EK,; American Dietetic Association. Position of the American Dietetic Association: Individualized nutrition approaches for older adults in health care communities. J Am Diet Assoc 2010; 110: 1549-1553.
124. Thomas DR, Cote TR, Lawhorne L, et al. Dehydration Council. Understanding clinical dehydration and its treatment. J Am Med Dir Assoc 2008; 9: 292-301.
125. Donoghue C,. Nursing home staff turnover and retention: An analysis of national level data. J Appl Gerontol 2010; 29: 89-106.
126. Feldman SM, Rosen R, DeStasio J,. Status of diabetes management in the nursing home setting in 2008: A retrospective chart review and epidemiology study of diabetic nursing home residents and nursing home initiatives in diabetes management. J Am Med Dir Assoc 2009; 10: 354-360.
127. Pandya N, Thompson S, Sambamoorthi U,. The prevalence and persistence of sliding scale insulin use among newly admitted elderly nursing home residents with diabetes mellitus. J Am Med Dir Assoc 2008; 9: 663-669.
128. Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists; American Diabetes Association. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 2009; 32: 1119-1131.
129. Umpierrez GE, Hellman R, Korytkowski MT, et al. Endocrine Society. Management of hyperglycemia in hospitalized patients in non-critical care setting: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2012; 97: 16-38.
130. Blaum C, Cigolle CT, Boyd C, et al. Clinical complexity in middle-aged and older adults with diabetes: The Health and Retirement Study. Med Care 2010; 48: 327-334.
131. Laiteerapong NIJ, Iveniuk J, John PM, et al. Classification of older adults who have diabetes by comorbid conditions, United States, 2005-2006. Prev Chronic Dis 2012; 9: E100.